Lorna Rodriguez-Rodriguez

4PUBLICATIONS
40CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 21, 2023
HCK Promotes High-Grade Serous Ovarian Cancer Tumorigenesis through CD44 and NOTCH3 Signaling.

Christen A Khella, Lucyann Franciosa, Lorna Rodirguez-Rodriguez

|Jun 24, 2022
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.

Eugenia Girda, June Hou, David Nelson

|Mar 31, 2022
Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.

Thanh H Dellinger, Ernest S Han, Mustafa Raoof

Pageof 1